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The idea of G protein-coupled receptors (GPCRs) coupling to
G protein solely in their active form was abolished when it was
found that certain ligands induce a G protein-coupled but inac-
tive receptor form. This receptor form interferes with signaling
of other receptors by sequestering G protein. However, the
spontaneous existence of this receptor species has never been
established. The aim of the present work was to evaluate the
existence of the spontaneous conformation of the receptor inac-
tively coupled to G protein able to interfere with the response of
other GPCRs. According to the law of mass action, receptor
overexpression should lead to increased amounts of all sponta-
neously occurring species. Based on this, we generated Chinese
hamster ovary (CHO-K1)-derived cell lines expressing various
amounts of the human histamineH2 receptor. In these systems,
the signaling of other endogenously and transiently expressed
GPCRs was attenuated proportionally to human H2 receptor
expression levels. G protein transfection specifically reverted
this attenuation, strongly suggesting hijacking of the G protein
from a common pool. Similar attenuation effects were observed
when the2- adrenergic receptorwas overexpressed, suggesting
that this is a more general phenomenon. Moreover, in human
mammary MDA-MB-231 cells, a consistent increase in the
response of other GPCRs was observed when endogenous
expression of 2-adrenergic receptor was knocked down using
specific small interfering RNAs. Our findings show that GPCRs
may interactwith the signaling of other receptors bymodulating
the availability of the G protein and suggest the existence of
GPCR spontaneous coupling to G proteins in an inactive form.
G protein-coupled receptors (GPCRs)2 form a large and
functionally diverse superfamily of proteins that transduce sig-
nals across cell membranes. Although much is known about
structural features of GPCRs involved in ligand recognition and
Gprotein binding, the actualmechanismunderlyingGPCR sig-
naling remains unclear.
Traditionally, agonist occupancy of GPCRs is believed to
result in a conformational change in the receptor, leading to
activation of G proteins (1). However, in genetically engineered
systems where receptors can be expressed at high densities,
Costa andHerz (2) noted that high levels of receptor expression
uncovered the existence of a population of spontaneously (unli-
ganded) active receptors, resulting in an elevated basal response
in the system.
The histamine H2 receptor (H2R) is an extensively charac-
terized member of the GPCR family, which in most systems
couples to Gs proteins to activate adenylyl cyclase (3–6). Com-
pared with other GPCRs, the H2R is unique in that the wild-
type receptor possesses a remarkably high degree of constitu-
tive activity. With a receptor density of 300 fmol/mg protein,
constitutive H2 receptor activity could be detected in Chinese
hamster ovary (CHO-K1) cells (7).
The notion that GPCRs also signal without an external
chemical trigger, i.e. in a constitutive or spontaneous manner,
resulted in a paradigm shift in the field of GPCR pharmacology.
Before the discovery of constitutive GPCR activity, efficacy was
considered only as a positive property (i.e. producing an
increased receptor activity, and only ligand-induced activation
of receptors was thought to induce G protein activity), but with
the discovery of spontaneous activation of G proteins by unli-
ganded receptors came the prospect of ligands that selectively
inhibit this spontaneous activation, specifically denominated
inverse agonists.
In an attempt to understand GPCR activation mecha-
nisms, several receptor occupancy models have been devel-
oped (8). The first that explicitly considered constitutive
activity was the extended ternary complex (ETC) model pre-
sented by Samama et al. (9), which includes two distinct con-
formational states of the receptor, an active (R*) and an inactive
(R) state, that exist in equilibrium even in the absence of drugs.
This spontaneous equilibrium determines the level of constitu-
tive activity because in the ETCmodel, only R* is able to couple
to theGprotein and is considered the responsible of basal activ-
ity (R*G).
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A further modification of the ETCmodel is the cubic ternary
complexmodel (CTC) (10–12), that extends the ETCmodel by
allowing G proteins to interact with receptors in both their
active and inactive states (i.e. R*G, and RG). Although the
development of the ETC model was made necessary by exper-
imental observations, the CTC model was originally proposed
in an attempt to explore theoretically the mathematical and
pharmacological implications that can be derived from permit-
ting G proteins to interact with receptors in their inactive and
active forms. Thus, the CTC model was the culmination of a
trend in increasing model complexity and statistical and ther-
modynamic completeness.
However, there is a growing body of evidence suggesting that
the CTC model is the only one capable of explaining some
experimental observations concerning the mechanism of
action of certain inverse agonists. Inverse agonists may act by
binding to an inactive, G protein-coupled form of the receptor,
decreasing basal activity of the specific GPCR of interest but
also in some cases the activity of other GPCRs that signal
through the sameG protein, via a proposed “molecular kidnap-
ping mechanism” (13–15).
According to the law ofmass action, receptor overexpression
leads to an increased amount of all spontaneously occurring
species. Hence, receptor overexpression should uncover a
receptor species spontaneously coupled to G protein but inac-
tive, able to interfere with other GPCRs that signal through the
same G protein pool.
In this study, aiming to characterize inactive spontaneously
GPCR species experimentally, we generated five CHO-K1 cell
clones stably transfectedwith the humanhistamineH2R.These
clones express different and increasing amounts of the receptor
protein and respond to ligand stimulation with an unaltered
pharmacological profile.
Surprisingly, in these clones the signaling of other Gs-cou-
pled receptors is attenuated proportionally to the H2R
expression levels. Similar results were obtained when
another Gs-coupled receptor, 2-adrenergic receptor
(AR), was overexpressed, indicating that this phenomenon
is not restricted to histamine receptors. Moreover, G protein
transfection specifically reverted this interference, strongly
suggesting that the mechanism is related to G protein hijack-
ing. Finally, we observed that knocking down the expression
of endogenously expressed AR leads to an increased ligand-
induced response of other Gs-coupled receptors, indicating
that this phenomenon is not restricted only to overexpres-
sion systems.
These results indicate that the CTC model prediction, stat-
ing that GPCRs spontaneously exist not only as a constitutive
active form (R*G) but also as a constitutive inactive form (RG),
was verified experimentally by its ability to sequester G protein
and interfere with the signaling of other GPCRs. This phenom-
enon could have serious physiological implications because it
was observed not only in genetically manipulated systems, but
also with endogenously expressed receptors.
EXPERIMENTAL PROCEDURES
Materials—CHO-K1dhfrandMDA-MB-231cellswereob-
tained from the American Type Culture Collection. Cell cul-
ture medium, antibiotics, isobutylmethylxanthine (IBMX),
cAMP,HTmedium supplement, G418, and bovine serumalbu-
min were obtained from Sigma. Amthamine, isoproterenol,
prostaglandin E2 (PGE2), salmon calcitonin (sCT), and tiotidine
were from Tocris Bioscience (Ellisville, MO). [3H]cAMP (31
Ci/mmol), [3H]tiotidine (75 Ci/mmol), and [3H]CGP12177 (30
Ci/mmol) were purchased from PerkinElmer Life Sciences.
Three siRNAs for AR were purchased from Invitrogen
(ADRB2 Stealth Select RNAiTM, HSS100258, HSS100259, and
HSS100260). Other chemicals used were of analytical grade.
pcDNA3-AR was a generous gift from Dr. M. Levin (INGEBI,
CONICET, Argentina). pcDNA3GS plasmids were generous
gifts from Dr. O. Cosso (Facultad de Ciencias Exactas y Natu-
rales, Universidad de Buenos Aires, Argentina). Human H2R
was previously cloned into the eukaryotic expression vector
pCEFL (16).
Cell Culture and Transfection—All cells were grown at 37 °C
in a humidified 5% CO2 incubator. CHO-H2R and CHO-mock
cells were cultured in Dulbecco’s modified Eagle’s medium
containing 10% fetal calf serum, 2 mM L-glutamine, 100 M
hypoxanthine, 16 M thymidine, 50 g/ml Gentamicin, and 0.8
mg/ml G418. Parental CHO-K1 cells were cultured in the same
mediumwithoutG418.MDA-MB-231 cells were grown inDul-
becco’s modified Eagle’s medium-F12 medium containing 10%
fetal calf serum and 50 g/ml Gentamicin.
For transfection CHO-K1 cells were grown to 80–90% con-
fluence. cDNA constructs were transfected into cells using
Lipofectamine 2000. The tranfection protocol was optimized as
recommended by the supplier (Invitrogen). After transfection,
five stable clones with different H2R levels were established by
G418 selection. A separate single clone containing the empty
vector was selected under the same conditions (CHO-mock).
Transfections with double stranded siRNA targeting AR at
20 nM concentration were also performed using Lipofectamine
2000 reagent (Invitrogen) according to the manufacturer’s
instructions. The three different sequences provided were used
separated or pooled.As control, nontargeting scrambled siRNA
was used. Transiently cDNA or siRNA-transfected cells were
assayed 48 h after transfection. Receptor expression was evalu-
ated by specific radioligand binding assay as described below.
cAMP Assays—Concentration-response assays were per-
formed by incubating the cells for 3 min in culture medium
supplemented with 1 mM IBMX at 37 °C, followed by a 7-min
exposure to different concentrations of ligands. The reaction
was stopped by the addition of ethanol. The ethanolic phase
was then dried and the residue resuspended in 50mMTris-HCl,
pH 7.4, 0.1% bovine serum albumin. cAMP content was deter-
mined by competition of [3H]cAMP for protein kinase A, as
described previously (17).
Radioligand Binding Assay—Triplicate assays were per-
formed in 50 mM Tris-HCl, pH 7.4. For saturation studies, 104
CHO-mock, CHO-H2R, or MDA-MB-231 cells/well of a
48-well cluster plate were incubated for 40 min at 4 °C with
increasing concentrations of [3H]tiotidine, ranging from 0.4 to
240 nM in the absence or in the presence of 1 M unlabeled
tiotidine or for 4 h at 4 °C with increasing concentrations of
[3H]CGP12177, ranging from 20 to 0.02 nM in the absence or in
the presence of 100 nM isoproterenol. The incubation was
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stopped by dilution with 3 ml of ice-cold 50 mM Tris-HCl, pH
7.4. After three washes with 3 ml of ice-cold buffer, the bound
fraction was collected in 200 l of ethanol. Experiments with
intact cells were performed at 4 °C to avoid ligand internaliza-
tion. The kinetic studies performed with 2 nM [3H]tiotidine at
4 °C showed that the equilibrium was reached at 30 min and
sustained for 4 h (data not shown).
Statistical Analysis—Binding data and sigmoidal dose-re-
sponse fittings were performed with GraphPad Prism 5.00 for
Windows (GraphPad Software, San Diego, CA). One-way anal-
ysis of variance followed by the Dunnett’s post test was per-
formed using GraphPad InStat version 3.01. Specific binding
was calculated by subtraction of nonspecific binding from total
binding.
RESULTS
H2R Overexpression Interferes with the Signaling of Other
Endogenously Expressed GPCRs—H2R constitutive activity (7)
and the triggering of cellular mechanisms tending to compen-
sate the activity of the signaling pathways when it is overex-
pressed (18) have been described. With the aim of character-
izing the effect of H2R overexpression on signaling of other
Gs-coupled receptors, we established CHO-K1 cells clones
stably transfected with cDNA encoding H2R. Several clones
were isolated, and five were selected based on their H2R
amounts (C1, C2A, C2B, C3, and C4). [3H]Tiotidine binding
assays performed on these clones yielded different Bmax val-
ues ranging from about 1.3105 to 2  106 sites/cell (Table
1). We observed for C1, C2A, and C2B the two different
binding sites previously described for H2 (14, 19, 20): the
high affinity site corresponding to the G protein-coupled
forms of the H2R (about 20% of total sites number) and the
low affinity site corresponding to the G protein-uncoupled
states. However, in C3 and C4 clones that expressed the
highest amounts of receptors, we observed only the low
affinity binding site (Table 1). The lack of the high affinity
site in these clones can be interpreted assuming that G pro-
FIGURE1.Dose-dependentcAMPproductionbyamthaminetreatment inH2-transfectedCHOcells.A, controlcells (mocktransfected,E) andclonesC1(F),C2A
(‚), C2B (Œ), C3 (), and C4 (f) cells were incubated for 7minwith increasing concentrations of amthamine at 37 °C in the presence of 1mM IBMX, and cAMP levels
weredetermined.Dataare themeanS.D. (error bars) of triplicateassays and representativeof at least six independentexperiments.B, variationof fittedparameters
for cAMP dose-response curves (maximal responses (f), basal levels (Œ), and pEC50) with H2R number is shown. Data are the mean  S.E. of six independent
experiments andarebest fit by ahyperbola (maximal responses) or a straight line (basal levels andpEC50)with slope significantly different fromzero (p0.01).Dotted
lines represent the 95% confidence interval of the curve.
TABLE 1
Binding of 3Htiotidine in CHO-K1-H2R clones
TheKd andBmax values were calculated using the equation for one or two binding sites. The simplermodel was chosen using the extra sum-of-squares F test unless p 0.05.
The table shows the mean S.E.; the number of determinations (n) is in parentheses.
Bmax H (103 sites/cell) Kd H Bmax L (103 sites/cell) Kd L H/L affinity ratio
nM nM
C1 (4) 22.9 1.5 5.28 0.47 109.6 9.9 23.54 1.98 17.33
C2A (4) 61.9 5.9 2.04 0.31 205.9 18.9 17.85 2.12 23.13
C2B (4) 50.9 5.5 1.74 0.21 237.6 19.0 21.64 2.41 17.60
C3 (3) 1254 49 30.76 2.98
C4 (3) 2063 70 26.15 2.56
G Protein Sequestering by GPCRs
14992 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 20•MAY 14, 2010
 at INSERM
, on M
ay 12, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
teins are in limiting quantity with respect to the amounts of
receptor overexpressed.
Concentration-response curves performed with the specific
H2 agonist amthamine showed an increase in cAMP basal
and stimulated levels and a decrease in pEC50 values accord-
ing to the increment on receptor amount. This behavior
agrees with predictions made, using simpler operational
models (21) (Fig. 1).
As stated in the Introduction, if a receptor is overexpressed,
all spontaneous species should be incremented as well, accord-
ing to its probability of occurrence. Considering this, receptor
overexpression may also lead to an increase in the hypothetical
species corresponding to an unliganded inactive G protein-
coupled form of the receptor.
According to the results obtained for [3H]tiotidine binding,
G protein amounts are in a limiting number regarding H2
receptors. As a consequence, over-
expression of a particular receptor
may cause a G protein kidnapping
and an interference in the response
of other GPCRs that signal through
the same subfamily of G proteins.
Hence, to test whether H2R
expression affects the signaling of
other GPCRs that transduce their
signals through the same G pro-
tein, we evaluated the ability of
signaling of CHO-K1 endog-
enously expressed Gs-coupled
receptors. To do this, we con-
firmed the presence and the func-
tionality of CT and PGE2 receptors
that were previously described on
the CHO-K1 cell line (22, 23)
(Fig. 2).
The only presence of the H2R is
able to reduce, in a receptor
number-dependent manner, the
CTR and PGE2R signaling. This
interference consists in a reduc-
tion of the ligand-induced maxi-
mal responses without signifi-
cantly affecting the pEC50 (Fig. 2
insets). This can be predicted with
any model of receptor occupancy
considering a limiting and dimin-
ishing G protein amounts avail-
able for signaling. As shown in Fig.
2 insets, the decrease in maximal
responses is best fit to an exponen-
tial decay equation, and the inter-
ference is more intense for the
PGE2 system, indicating that the
propensity to be interfered is dif-
ferent for each GPCR. It is worth
noting that, in saturation binding
assays, the number and the affinity
constants of the aforementioned
receptors remained unchanged (data not shown).
Overall, these results may be explained by the kidnapping of
available G protein in an inactive form by overexpressed H2R.
To confirm this hypothesis, we attempt to overexpress G pro-
tein to increase its availability.
Gs Overexpression Reverts the H2R Interference on Calcito-
nin and PGE2 Signaling—The results described above may be
explained by the kidnapping of available Gs protein in an inac-
tive form by overexpressedH2R. If this hypothesis was right, an
increase in the amounts of G proteins of this family would
counteract the effect of H2R on the sCT and PGE2 response in
CHO clones.
Fig. 3 shows that the interference was abolished on C1, C2A,
and C2B clones, both for CTR and PGE2R ligand-induced sig-
naling but that this recovery effect lost efficacy on the clones
where H2R number is higher (C3 and C4 clones). These results
FIGURE 2. Reduction of the dose-dependent cAMP production by sCT and PGE2 treatment with H2R
number in CHO cells. Control cells (mock-transfected, E) and clones C1 (F), C2A (‚), C2B (Œ), C3 (), and C4
(f) cells were incubated for 7minwith increasing concentrations of sCT (A) or PGE2 (B) at 37 °C in the presence
of 1 mM IBMX, and cAMP levels were determined. Data are themean S.D. (error bars) of triplicate assays and
representative of at least six independent experiments. Right, variation of fitted parameters for cAMP dose-
response curves (maximal responses and pEC50) with H2R number. Data are the mean S.E. from three to six
independentexperiments andarebest fit byan exponential decay (maximal responses) or a straight line (pEC50),
whose slope is not significantly different from zero (p  0.05). Dotted lines represent the 95% confidence
interval of the curve.
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confirm that the interference observed could be due to the kid-
napping of the G protein by H2R and strengthen the concept
that the stoichiometry of the different signaling partners is cru-
cial to determine the signaling ability of a system.
H2R Expression Also Attenuates the Signaling of Other Exog-
enously Expressed GPCRs—To evaluate further the attenuating
effect of H2R expression, considering a role of an endogenous
regulation as partially responsible for the observed interfer-
ence, we also studied the signaling of a heterologously
expressed GPCR, the AR. When AR was transiently trans-
fected into the different CHO-H2R clones we observed no dif-
ferences on receptor expression by [3H]CGP12177 saturation
binding experiments (data not shown). However, we could
observe that its signaling is also attenuated in an H2R number-
dependent manner. When plotted as isoproterenol maximal
response versus H2R number, the data also best fit a one-phase
exponential decay, but the curve was shifted to the right, indi-
cating that H2R is less efficacious in interfering with the AR
signaling (Fig. 4). When AR is expressed on CHO cells, its
presence is also able to attenuate sCT and PGE2 signaling (Fig.
5, A and B), and when expressed on CHO-H2R cells it is also
able to interfere with H2R-mediated response (Fig. 5C), indi-
cating that this interference phenomenon is not restricted to
any chosen receptor pair.
As shown before, H2R overexpression led to a concomitant
increase on second messenger basal levels (Fig. 1B). However,
surprisingly, the same effect was not observed when AR is
overexpressed. In the latter case, the basal levels of all clones
were unchanged or diminished (Fig. 4A). To evaluate this strik-
ing effect better, we overexpressed Gs protein. Under these
experimental circumstances, we were able to observe the
expected increase on cAMP levels, but AR co-expression was
capable of diminishing this magnified basal response (Fig. 6).
This was tested using three different Gs and AR plasmid
concentrations, and the results were reproducible for every
condition (data not shown). These results may be indicative of
the natural tendency of a GPCR to adopt distinct spontaneous
conformations, showing thatARhasmore tendency thanH2R
to adopt a spontaneous conformation able to bindGproteins in
an inactive state.
Knockdown of Endogenous AR Augments the Response of
Other GPCRs—Previously, it has been reported that although
heterologously transfected GPCRs share a common G protein
pool, endogenously expressed receptors by naïve cells activate
different pools ofGprotein (24). Therefore, to evaluatewhether
this interference phenomenon is restricted to exogenously
expressed receptors, we utilized a cell line that endogenously
expresses the set ofGs-coupledGPCRs examined in this work.
We chose MDA-MB-231 cells, a human mammary carcinoma
cell line that endogenously expresses AR and H2R (25, 26). In
this cell line, transfection with siRNA targeted against AR
diminished membrane receptor number approximately 80%
when measured by saturation binding experiments and
decreased isoproterenol-induced cAMP levels 60%. However,
although siRNA transfection did not change the H2R number,
the H2R response was significantly increased (22.01 2.73 ver-
sus 51.82  3.47 pmol/well), consistent with our hypothesis
(Fig. 7). Furthermore, the potentiating effect of the AR-spe-
cific siRNA was observed as well for other endogenously
expressed receptors such as CTR and PGE2R (27, 28) (Fig. 7).
These results support the fact that the only presence of a GPCR
can affect the response of another receptor not only in geneti-
cally manipulated cells, but also in endogenous expression
systems.
DISCUSSION
Threemain conclusions can be drawn fromour studies. First,
humanH2R overexpression inCHO-K1 cells shows thatH2R is
able to interfere with CTR and PGE2R signaling. Second, tran-
sient expression of AR shows that this is not exclusive of H2R.
Third, experiments performed knocking down the endogenous
expression of AR in MDA-MB-231 cells show that this phe-
nomenon is not restricted to overexpression systems and that it
can be evidenced in physiological conditions.
We have previously described that certain inverse agonists
acting on histaminergic receptors interferewith the signaling of
other receptors that share common G subunits (14, 15). This
interference is thought to be caused by the ligand-induced sta-
bilization of a G protein-coupled form of the receptor, which is
FIGURE 3. Effect of Gs subunit transfection on sCT- and PGE2-induced
cAMP response in CHO-H2 clones. Control cells (black bar), CHO-H2 clones
transfected with empty vector (empty bars), and CHO-H2 clones transfected
with a vector encoding for the Gs G protein subunit (gray bars) were incu-
bated for 7minwith increasing concentrations of sCT (A) and PGE2 (B) at 37 °C
in the presence of 1 mM IBMX, and cAMP levels were determined. Data are
expressed as the span of the sigmoidal dose-response fitted curves. Data
were calculated as the mean  S.E. (error bars) of four independent experi-
ments. ***, p 0.01.
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unable to evoke a response. Such receptor conformation could
be responsible for a G protein kidnapping that may invoke the
aforementioned interference.
It could be tempting to explain the interference on other
GPCR signaling observed in H2R overexpression systems in
terms of the induction of adaptative mechanisms such as phos-
phodiesterase activity augmentation or an increased general
receptor internalization. However, the first possibility was
ruled out because in all cases cAMP levels were evaluated in
presence of the phosphodiesterase inhibitor IBMX. Likewise,
the assessed GPCRs that showed a decreased response showed
no modification in protein levels and Kd values (data not
shown), and similarly, when the AR was knocked down, the
H2R response was increased without variation on receptor
number as well. Overall, our results are better interpreted
considering the spontaneous existence of a receptor confor-
mation coupled to G protein but inactive, which was con-
firmed by the reversion of this effect when the specific G
protein is overexpressed.
The competition of two or more receptors for the same
pool of G proteins could be assumed to be the cause of cer-
tain previously observed effects, such as several types of syn-
ergism and cross-signaling. For example, there have been
documented synergistic interactions between D1 and D2
dopamine receptors (29),  and  opioid receptors (30), and
muscarinic and 2-adrenergic receptors (31). Although
receptor dimerization, oligomerization, and co-localization
have all been proposed as mechanisms for these cross-sig-
naling processes, it appears that other mechanisms can also
lead to GPCR signaling modulation.
Assuming the collision-coupling
model of membrane receptor sig-
naling (32, 33), which allows for
receptors and G proteins to diffuse
freely in the membrane, if the latter
are in a limiting number, it is possi-
ble to anticipate an interference of a
GPCR with the signaling of other
receptors based on the redistribu-
tion of the subabundant G proteins.
That may be the case for the
reported ligand competitive behav-
ior, in which the stimulation
achieved by the addition of two ago-
nists acting on different GPCRs is
less than the sum of the activation
caused by the individual receptors
alone (e.g. CB1 and  opioid recep-
tors) (24). It is worth noting that in
that work, the authors concluded
that exogenously transfected re-
ceptors share a common G protein
pool, whereas endogenously ex-
pressed receptors interact with dis-
tinct pools. Contrarily, the results
obtained knocking down the
expression of endogenous AR
indicate that the set of GPCRs stud-
ied share a common G protein pool, on which a receptor
could signal at the expense of the others. In accordance with
our results, it has been found that ligand-activated V1 vaso-
pressin receptor and 1-adrenoreceptor endogenously
expressed on rat hepatocytes and receptors for the chemo-
tactic factors fMet-Leu-Phe and C5a endogenously
expressed on human HL 60 cells compete for the same lim-
ited pool of G proteins (34, 35).
Remarkably, our experiments show that solely the expres-
sion of a GPCR dampens the agonist-induced signaling of
endogenously or heterologously expressed receptors. More-
over, overexpression of the AR is able to diminish elevated
cAMP levels resulting from Gs overexpression, strengthen-
ing our proposal of the G protein-coupled but inactive recep-
tor form.
In line with our results, it has been described that 5HT7 sero-
tonin receptor attenuates adenylyl cyclase activation by AR
and prostanoid EP receptor. However, in that case, neither Gs
nor adenylyl cyclase overexpression is able to reverse the inter-
ference effect, indicating that the mechanism underlying their
observations is different (36). Furthermore, Stephan and co-
workers have shown that the constitutive abnormal signaling of
mutated yeast pheromone receptors Ste2p and Ste3p is sup-
pressed upon co-expression with wild-type but not G protein
coupling-defective receptors, suggesting that wild-type recep-
tors may sequester a limiting pool of G proteins (37). Consid-
ering the results obtained on the carcinoma cell line, the phe-
nomenon herewith described could have serious implications
regarding the effects of an unbalance of protein expression on
receptor signaling.
FIGURE 4. Reduction of the dose-dependent cAMP production by isoproterenol treatment with H2R
number in transfected CHO cells. A, control cells (mock-transfected, E) and clones C1 (F), C2A (‚), C2B
(Œ), C3 (), and C4 (f) were transfected with a vector encoding for AR. 48 later they were incubated for
7 min with increasing concentrations of isoproterenol at 37 °C in the presence of 1 mM IBMX, and cAMP
levels were determined. Data are the mean S.D. (error bars) of assay triplicates and are representative of
at least three independent experiments. The C4 clone did not render a dose-dependent cAMP production
and cannot be fitted to a sigmoidal equation. B, variation of fitted parameters for cAMP dose-response
curves (maximal responses and pEC50) with H2R number is shown. Data are the mean  S.E. of three
independent experiments and are best fit by an exponential decay (maximal responses) or a straight line
(pEC50), whose slope is not significantly different from zero (p  0.05). Dotted lines represent the 95%
confidence interval of the curve. In the last plot, the C4 clone is missing because pEC50 could not be
estimated.
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Hasseldine and co-workers (38) have described the signaling
of the -adrenergic system in TG4 mice, a strain that specifi-
cally overexpresses 2AR in cardiac tissue. In this system, as a
result of its overexpression, 2AR couples simultaneously to
Gs and Gi pathways, but for yet unknown reasons 1AR
cardiac signaling is dampened in the transgenic mice. This
surprising result could be interpreted in terms of the G pro-
tein-hijacking mechanism proposed, bringing out the possi-
ble physiological relevance.
As mentioned above, GPCRs are overexpressed in various
malignancies. For instance, there has been conducted an in
silico approach demonstrating overexpression of several
GPCRs in primary tumor cells, including chemokine recep-
tors and protease-activated receptors, neuropeptide recep-
tors, adenosine A2B receptor, P2Y purinoceptor, calcium-
sensing receptor, and metabotropic glutamate receptors.
Analysis of cancer samples in different disease stages also
suggests that some GPCRs, such as endothelin receptor A,
may be involved in early tumor progression, and others, such
as CXCR4, may play a critical role in tumor invasion and
metastasis (39).
Besides cancer, there have been described other conditions
in which receptors are overexpressed (e.g. schizophrenia and
dopamine D4 receptors) (40) and presumably H2R and certain
heart disease states (41)). In those cases, as well as some easily
anticipated consequences (i.e. an elevation on second messen-
FIGURE 5. Reduction of the dose-dependent cAMP production by sCT,
PGE2, and amthamine when AR is expressed in CHO cells. A and B, con-
trol cells (mock-transfected,F) andAR-transfected CHO cells (E) were incu-
bated for 7minwith increasing concentrations of sCT and PGE2 at 37 °C in the
presence of 1 mM IBMX, and cAMP levels were determined. Data are the
mean S.D. (error bars) of triplicate assays and are representative of at least
three independent experiments. Additional plots show the variation of best
fit bottom, tops, and pEC50. Data are the mean  S.E. of three independent
experiments. ***, p  0.01. C, effect of AR expression on CHO-H2 clone
amthamine-induced maximal response is shown. CHO-H2 clones were incu-
bated for 7 min with increasing concentrations of amthamine at 37 °C in the
presence of 1 mM IBMX, and cAMP levels were determined. Data plotted are
the mean  S.E. of dose-response curve best fit tops of three independent
experiments. In all cases, p 0.5 versus control.
FIGURE6.EffectofGs,H2R, andARtransfectiononCHOcells cAMPbasal
levels. Control cells (mock, black bars) or transfected with Gs, H2R, and AR
were incubated for 7min with 1mM IBMX, and basal cAMP levels were deter-
mined. Data are themean S.E. (error bars) of five independent experiments.
***, p 0.01.
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ger levels or promiscuous effects on G protein coupling) this
plausible negative interference on other receptor signaling
should be taken into account.
In summary, we have shown that the human H2R and AR
have the ability to block the signaling by other endogenous or
exogenously expressed Gs-coupled receptors. Sequestration
of G proteins by these receptors is well accommodated by CTC
model, and our study suggests that GPCRs may act as proteins
controlling the signaling of other receptors sharing a common
and limiting G protein pool.
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